Literature DB >> 12383011

Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.

Prashant S Kharkar1, Bhavik Desai, Harsukh Gaveria, Bharat Varu, Rajesh Loriya, Yogesh Naliapara, Anamik Shah, Vithal M Kulkarni.   

Abstract

Three-dimensional quantitative structure-activity relationship (3D QSAR) methods, comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA), were applied on a series of 1,4-dihydropyridines possessing antitubercular activity. The study was performed using 33 compounds, in which 22 molecules were used for the derivation of the 3D QSAR models (training set) and 11 molecules were used to evaluate the predictive ability of the derived models (test set). Superimpositions were performed using three alignment rules: atom-based fitting, SYBYL QSAR rigid body field fit of the steric and electrostatic fields of the molecules, and flexible fitting (multifit). Both methods were analyzed in terms of their predictive abilities and produced comparable results with high internal as well as external predictivities. Steric and electrostatic fields of the inhibitors were found to be relevant descriptors for SAR. Use of lowest unoccupied molecular orbital energies or ClogP as additional descriptors in the QSAR table did not improve the significance of the 3D QSAR models. Both CoMFA and CoMSIA models based on multifit alignment showed better correlative and predictive properties than other models. A QSAR study using genetic function approximation was also performed for the same set of molecules using different types of physicochemical descriptors to deal with cell-based activity data. The QSAR models revealed the importance of spatial properties and conformational flexibility of side chains for antitubercular activity. Inclusion of fractional polar solvent accessible surface area as a descriptor in the model generation resulted in models with significant internal and external predictivities for the same test set molecules, which may support the possible mode of action of these compounds.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383011     DOI: 10.1021/jm020217z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  3D-QSAR illusions.

Authors:  Arthur M Doweyko
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

2.  Novel semi-automated methodology for developing highly predictive QSAR models: application for development of QSAR models for insect repellent amides.

Authors:  Jayendra B Bhonsle; Apurba K Bhattacharjee; Raj K Gupta
Journal:  J Mol Model       Date:  2006-09-20       Impact factor: 1.810

3.  Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.

Authors:  Atul T Manvar; Raghuvir R S Pissurlenkar; Vijay R Virsodia; Kuldip D Upadhyay; Dinesh R Manvar; Arun K Mishra; Hrishikesh D Acharya; Alpesh R Parecha; Chintan D Dholakia; Anamik K Shah; Evans C Coutinho
Journal:  Mol Divers       Date:  2009-06-24       Impact factor: 2.943

4.  Understanding the Structural Requirements of Hybrid (S)-6-((2-(4-Phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol and its Analogs as D2/D3 Receptor Ligands: A Three-Dimensional Quantitative Structure-Activity Relationship (3D QSAR) Investigation.

Authors:  Gyan Modi; Horrick Sharma; Prashant S Kharkar; Aloke K Dutta
Journal:  Medchemcomm       Date:  2014-09-01       Impact factor: 3.597

5.  Antimicrobial activity of novel c2-substituted 1,4-dihydropyridine analogues.

Authors:  Petra Olejníková; L'ubomír Svorc; Denisa Olšovská; Anna Panáková; Zuzana Vihonská; Katarína Kovaryová; Stefan Marchalín
Journal:  Sci Pharm       Date:  2014-01-12

Review 6.  Synthesis and structural activity relationship study of antitubercular carboxamides.

Authors:  D I Ugwu; B E Ezema; F U Eze; D I Ugwuja
Journal:  Int J Med Chem       Date:  2014-12-30

7.  Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety.

Authors:  Maryam Iman; Asghar Davood; Mahboubeh Lotfinia; Golnoush Dehqani; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

8.  Design, Synthesis and Evaluation of Antitubercular Activity of Novel Dihydropyridine Containing Imidazolyl Substituent.

Authors:  Maryam Iman; Asghar Davood; Golnoush Dehqani; Mahboubeh Lotfinia; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.